These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 9089286)

  • 21. The ubiquitin-proteasome pathway and proteasome inhibitors.
    Myung J; Kim KB; Crews CM
    Med Res Rev; 2001 Jul; 21(4):245-73. PubMed ID: 11410931
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modes of regulation of ubiquitin-mediated protein degradation.
    Kornitzer D; Ciechanover A
    J Cell Physiol; 2000 Jan; 182(1):1-11. PubMed ID: 10567911
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Degradation of the epstein-barr virus latent membrane protein 1 (LMP1) by the ubiquitin-proteasome pathway. Targeting via ubiquitination of the N-terminal residue.
    Aviel S; Winberg G; Massucci M; Ciechanover A
    J Biol Chem; 2000 Aug; 275(31):23491-9. PubMed ID: 10807912
    [TBL] [Abstract][Full Text] [Related]  

  • 24. O-GlcNAc modification is an endogenous inhibitor of the proteasome.
    Zhang F; Su K; Yang X; Bowe DB; Paterson AJ; Kudlow JE
    Cell; 2003 Dec; 115(6):715-25. PubMed ID: 14675536
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ubiquitin-like proteins: meet the family.
    Wilkinson CR
    Semin Cell Dev Biol; 2004 Apr; 15(2):199-200. PubMed ID: 15209379
    [No Abstract]   [Full Text] [Related]  

  • 26. Ubiquitin-proteasome-dependent proteolysis in skeletal muscle.
    Attaix D; Aurousseau E; Combaret L; Kee A; Larbaud D; Rallière C; Souweine B; Taillandier D; Tilignac T
    Reprod Nutr Dev; 1998; 38(2):153-65. PubMed ID: 9638789
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27.
    Pagano M; Tam SW; Theodoras AM; Beer-Romero P; Del Sal G; Chau V; Yew PR; Draetta GF; Rolfe M
    Science; 1995 Aug; 269(5224):682-5. PubMed ID: 7624798
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of the ATP-ubiquitin-proteasome pathway in skeletal muscle of cachectic rats bearing a hepatoma.
    Baracos VE; DeVivo C; Hoyle DH; Goldberg AL
    Am J Physiol; 1995 May; 268(5 Pt 1):E996-1006. PubMed ID: 7539218
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insulin inhibits the ubiquitin-dependent degrading activity of the 26S proteasome.
    Bennett RG; Hamel FG; Duckworth WC
    Endocrinology; 2000 Jul; 141(7):2508-17. PubMed ID: 10875252
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deubiquitinating enzymes: a new class of biological regulators.
    D'Andrea A; Pellman D
    Crit Rev Biochem Mol Biol; 1998; 33(5):337-52. PubMed ID: 9827704
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ubiquitin in chains.
    Pickart CM
    Trends Biochem Sci; 2000 Nov; 25(11):544-8. PubMed ID: 11084366
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Muscle wasting in insulinopenic rats results from activation of the ATP-dependent, ubiquitin-proteasome proteolytic pathway by a mechanism including gene transcription.
    Price SR; Bailey JL; Wang X; Jurkovitz C; England BK; Ding X; Phillips LS; Mitch WE
    J Clin Invest; 1996 Oct; 98(8):1703-8. PubMed ID: 8878419
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of the ubiquitin-proteasome pathway in sepsis-induced muscle catabolism.
    Hasselgren PO
    Mol Biol Rep; 1999 Apr; 26(1-2):71-6. PubMed ID: 10363650
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 'ER degradation' of a mutant yeast plasma membrane protein by the ubiquitin-proteasome pathway.
    Galan JM; Cantegrit B; Garnier C; Namy O; Haguenauer-Tsapis R
    FASEB J; 1998 Mar; 12(3):315-23. PubMed ID: 9506475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of proteolysis.
    Attaix D; Combaret L; Pouch MN; Taillandier D
    Curr Opin Clin Nutr Metab Care; 2001 Jan; 4(1):45-9. PubMed ID: 11122559
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heregulin beta1 induces the down regulation and the ubiquitin-proteasome degradation pathway of p185HER2 oncoprotein.
    Magnifico A; Tagliabue E; Ardini E; Casalini P; Colnaghi MI; Ménard S
    FEBS Lett; 1998 Jan; 422(2):129-31. PubMed ID: 9489990
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Degradation of the 74 kDa form of L-histidine decarboxylase via the ubiquitin-proteasome pathway in a rat basophilic/mast cell line (RBL-2H3).
    Tanaka S; Nemoto K; Yamamura E; Ohmura S; Ichikawa A
    FEBS Lett; 1997 Nov; 417(2):203-7. PubMed ID: 9395296
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The proteasome: a protein-destroying machine.
    Tanaka K; Chiba T
    Genes Cells; 1998 Aug; 3(8):499-510. PubMed ID: 9797452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The ubiquitin-proteasome proteolytic pathway.
    Ciechanover A
    Cell; 1994 Oct; 79(1):13-21. PubMed ID: 7923371
    [No Abstract]   [Full Text] [Related]  

  • 40. Glucose activation of the yeast plasma membrane H+-ATPase requires the ubiquitin-proteasome proteolytic pathway.
    de la Fuente N; Maldonado AM; Portillo F
    FEBS Lett; 1997 Jul; 411(2-3):308-12. PubMed ID: 9271226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.